Symtuza®
Company
Janssen Therapeutics
Use
Treatment of HIV-1 infection
Features
A combination of four drugs designed for a complete treatment regimen for HIV-1. FDA approved in 2018.
NIH Contribution
NIH research on the development of HIV treatments.
HHS Institute/Agency
NCI
Inventor(s)
Erickson, J. et al.
Year
2018
